Brain Cancer Press Releases
Breaking News
-
Amarantus BioSciences Licenses Disease Diagnostic Biomarker Test from Power3 Medical Products
Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products /EINPresswire.com/ SUNNYVALE, CA and THE WOODLANDS, TX - January 23, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology...
-
Study comparisons of exacerbations of Asthma & COPD
SMI is proud to present the 8th annual conference… Asthma & COPD Monday 16th & Tuesday 17th April 2012, Copthorne Tara Hotel, London /EINPresswire.com/ SMi present their 8th annual Asthma & COPD event to be held in London on Monday 16th...
-
Steve Sommer, M.D., Ph.D., Founder, OncoMOTOR to Present Investor Opportunities at OneMedForum 2012
OncoMOTOR is a new company focused on developing highly sensitive diagnostic tests that can be used in either the doctor's office or hospital to enable the very early diagnosis of cancer. /EINPresswire.com/San Francisco, CA - Dr. Steve Sommer...
-
Revolutionary Healthcare Concept Fills Critical Niche
What about the other 23 hours? /EINPresswire.com/ Wilmington DE: Advances in awareness, early detection, prevention and the treatment of cancer mean cancer survival rates are increasing according to National Cancer Institute Cancer Trends...
-
Brain Cancer and Cell Phones - A Personal Account of a Psychologist's Battle with Glioblastoma
/EINPresswire.com/ Herman Lowe, who has been battling brain cancer for over two years, has written a free online book about his journey and what he has done to try to help others with this deadly disease. Lowe, a semi-retired clinical psychologist,...
Press Releases
Brain Cancer
-
President Obama to Host White House Science Fair
Event Will Highlight Winners of National Science, Technology, Engineering and Math (STEM) Competitions WASHINGTON, DC -- On Tuesday, February 7th, President Obama will host the second White House Science Fair celebrating the student winners...
-
Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer
Discovery Predicts Patient Sensitivity to Important Drug Target in Deadly Brain Cancer Study may aid in development of improved therapies for glioblastoma PR Newswire GRAND RAPIDS,...
-
Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer PR Newswire WASHINGTON and NEW YORK , Feb. 6, 2012 /PRNewswire/...
-
Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion
Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion PR Newswire MOSCOW , February 6, 2012 /PRNewswire/ -- N.N. Burdenko Neurosurgical Institute improves treatment of patients with multiple metastases...
-
Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion
Largest Neurosurgical Center in Russia Acquires Elekta's Leksell Gamma Knife Perfexion N.N. Burdenko Neurosurgical Institute improves treatment of patients with multiple metastases PR Newswire MOSCOW ,...
-
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others
Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others PR Newswire NEW YORK , Feb. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market...
-
St. Jude Children's Research Hospital Celebrates 50 Years
St. Jude Children's Research Hospital Celebrates 50 Years PR Newswire Tennessee Governor Proclaims February as St. Jude Month MEMPHIS, Tenn. , Feb. 4, 2012 /PRNewswire-USNewswire/ -- In 1962, St. Jude Children's Research...
-
Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC PR Newswire SAN DIEGO , Feb. 3, 2012 /PRNewswire/ -- Tocagen Inc. today announced...
-
Texans for Stem Cell Research (TSCR) and CORE Health Foundation (CHF) Collaborate to Advance Medical Research Needs
Stroke Stem Cell Clinical Trials and Potential Medical School Discussed AUSTIN, TX, February 03, 2012 /24-7PressRelease/ -- Texans For Stem Cell Research (TSCR), a non-partisan, non-profit 501(c)3 volunteer organization dedicated to the advancement...
-
High Triglyceride Levels Found to Predict Stroke in Older Women
High Triglyceride Levels Found to Predict Stroke in Older Women PR Newswire A Stronger Link than Cholesterol Levels to Ischemic Stroke BRONX, N.Y. , Feb. 2, 2012 /PRNewswire-USNewswire/ -- In a surprising finding...
-
Tumeric and Curcumin Offer Powerful Anti-Cancer Health Benefits Naturally
Tumeric and Curcumin Offer Powerful Anti-Cancer Health Benefits Naturally Inexpensive and widespread tumeric and curcumin spice offer many health benefits PR Newswire PHILADELPHIA , Feb. 2, 2012 /PRNewswire/ -- Commonly used in...
-
Del Mar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of Glioma
DelMar Pharma today announced that the United States FDA Office of Orphan Products Development has granted orphan drug designation for VAL-083 for the treatment of glioma, including glioblastoma multiforme (GBM), the most common and aggressive...
-
Nitric Oxide - Therapeutics, Markets and Companies
Nitric Oxide - Therapeutics, Markets and Companies PR Newswire NEW YORK , Feb. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Nitric Oxide - Therapeutics, Markets...
-
Top 20 Fluoride News Stories of 2011
Top 20 Fluoride News Stories of 2011 PR Newswire NEW YORK , Feb. 1, 2012 /PRNewswire-USNewswire/ -- Misinformed fluoridation promoters falsely assure unquestioning and confused legislators that fluoride-laced water...
-
Cycle for Survival
Cycle for Survival National Memorial Sloan-Kettering Cancer Center fundraising event advances research and treatments for rare cancers PR Newswire NEW YORK , Feb. 1, 2012 /PRNewswire/ -- More than 10,000 people nationwide will...
Follow us
What people say
Our Partners
© 2005-2012